indefinite antiviral therapy may be required after surgical resection for hepatocellular carcinoma complicating chronic hepatitis b

نویسندگان

qiang wei department of surgery, key lab of combined multi-organ transplantation, ministry of public health, division of hepatobiliary and pancreatic surgery, first affiliated hospital, zhejiang university school of medicine, hangzhou, 310003, china

xiao xu department of surgery, key lab of combined multi-organ transplantation, ministry of public health, division of hepatobiliary and pancreatic surgery, first affiliated hospital, zhejiang university school of medicine, hangzhou, 310003, china

qi ling department of surgery, key lab of combined multi-organ transplantation, ministry of public health, division of hepatobiliary and pancreatic surgery, first affiliated hospital, zhejiang university school of medicine, hangzhou, 310003, china

shusen zheng department of surgery, key lab of combined multi-organ transplantation, ministry of public health, division of hepatobiliary and pancreatic surgery, first affiliated hospital, zhejiang university school of medicine, hangzhou, 310003, china

چکیده

this report describes a 66-year-old male who had a long history of hepatitis b virus (hbv) infection. he was found hepatocellular carcinoma (hcc) 5 months after lamivudine resistance mutation and then received a successful hepatectomy. three years later, hepatitis b envelope antigen seroconversion was achieved and nucleoside analogs were discontinued. after the withdrawn of antiviral treatment, hbv reactivated and acute-on-chronic liver failure (aclf) occurred. anti-hbv treatment improved the patient clinical condition. three months after the remission of aclf, the patient was diagnosed as hcc recurrence and received another hepatectomy. this case illustrates indefinite duration antiviral therapy and tight viral control should be performed in patients with hbv-related hcc.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Indefinite antiviral therapy may be required after surgical resection for hepatocellular carcinoma complicating chronic hepatitis B

This report describes a 66-year-old male who had a long history of hepatitis B virus (HBV) infection. He was found hepatocellular carcinoma (HCC) 5 months after lamivudine resistance mutation and then received a successful hepatectomy. Three years later, hepatitis B envelope antigen seroconversion was achieved and nucleoside analogs were discontinued. After the withdrawn of antiviral treatment,...

متن کامل

Hepatocellular carcinoma complicating chronic granulomatous hepatitis.

The development of hepatocellular carcinoma, is reported in a patient with chronic granulomatous hepatitis after a seven year interval in which clinical and biochemical improvement had occurred on corticosteroid therapy and in whom, the development of cirrhosis was excluded by liver biopsy.

متن کامل

Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?

متن کامل

Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy

OBJECTIVE To assess the effect of antiviral therapy for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after radical hepatectomy. METHODS A total of 478 HBV-related HCC patients treated by radical hepatectomy were retrospectively collected. Patients in the treatment group (n=141) received postoperative lamivudine treatment (100 mg/d), whereas patients in the control group (n=3...

متن کامل

Antiviral therapy for chronic hepatitis B.

The goal of antiviral therapy for chronic hepatitis B is to prevent the development of cirrhosis and hepatocellular carcinoma. End points, including viral suppression, alanine aminotransferase normalization, hepatitis B e antigen loss, hepatitis B surface antigen loss, and improvement in liver histology, are used to determine treatment success. Treatment is based on hepatitis B virus (HBV) repl...

متن کامل

Current Antiviral Therapy for Chronic Hepatitis B

During the past decade, major breakthroughs have been achieved in treatment of chronic hepatitis B. Currently, three therapeutic agents are approved for chronic hepatitis B: interferon-alpha, lamivudine and adefovir dipivoxil. In patients with HBeAgpositive chronic hepatitis B, all of these drugs achieve HBeAg loss (24-33%) and anti-HBe seroconversion (12-30%) rates that are superior to those o...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}

عنوان ژورنال:

journal of research in medical sciences

جلد ۱۸، شماره ۸، صفحات ۷۲۶-۰

کلمات کلیدی

[ ' c a r c i n o m a ' , ' h e p a t i t i s b v i r u s ' , ' h e p a t o c e l l u l a r ' , ' r e c u r r e n c e ' , ' t h e r a p y n o r m a l 0 f a l s e f a l s e f a l s e e n ' , ' u s x ' , ' n o n e f a r n / * s t y l e d e f i n i t i o n s * / r n t a b l e . m s o n o r m a l t a b l e r n t { m s o ' , ' s t y l e ' , ' n a m e ' , ' & ' , ' q u o t ' , ' t a b l e n o r m a l & ' , ' q u o t ' , ' m s o ' , ' t s t y l e ' , ' r o w b a n d ' , ' s i z e ' , 0 , ' m s o ' , ' t s t y l e ' , ' c o l b a n d ' , ' s i z e ' , 0 , ' m s o ' , ' s t y l e ' , ' n o s h o w ' , ' y e s ' , ' m s o ' , ' s t y l e ' , ' p r i o r i t y ' , 9 9 , ' m s o ' , ' s t y l e ' , ' q f o r m a t ' , ' y e s ' , ' m s o ' , ' s t y l e ' , ' p a r e n t ' , ' & ' , ' q u o t ' , ' & ' , ' q u o t ' , ' m s o ' , ' p a d d i n g ' , ' a l t ' , ' 0 c m 5 . 4 p t 0 c m 5 . 4 p t ' , ' m s o ' , ' p a r a ' , ' m a r g i n ' , ' t o p ' , ' 0 c m ' , ' m s o ' , ' p a r a ' , ' m a r g i n ' , ' r i g h t ' , ' 0 c m ' , ' m s o ' , ' p a r a ' , ' m a r g i n ' , ' b o t t o m ' , ' 1 0 . 0 p t ' , ' m s o ' , ' p a r a ' , ' m a r g i n ' , ' l e f t ' , ' 0 c m ' , ' l i n e ' , ' h e i g h t ' , ' 1 1 5 % ' , ' m s o ' , ' p a g i n a t i o n ' , ' w i d o w ' , ' o r p h a n ' , ' f o n t ' , ' s i z e ' , ' 1 1 . 0 p t ' , ' f o n t ' , ' f a m i l y ' , ' & ' , ' q u o t ' , ' c a l i b r i & ' , ' q u o t ' , ' & ' , ' q u o t ' , ' s a n s ' , ' s e r i f & ' , ' q u o t ' , ' m s o ' , ' a s c i i ' , ' f o n t ' , ' f a m i l y ' , ' c a l i b r i ' , ' m s o ' , ' a s c i i ' , ' t h e m e ' , ' f o n t ' , ' m i n o r ' , ' l a t i n ' , ' m s o ' , ' f a r e a s t ' , ' f o n t ' , ' f a m i l y ' , ' & ' , ' q u o t ' , ' t i m e s n e w r o m a n & ' , ' q u o t ' , ' m s o ' , ' f a r e a s t ' , ' t h e m e ' , ' f o n t ' , ' m i n o r ' , ' f a r e a s t ' , ' m s o ' , ' h a n s i ' , ' f o n t ' , ' f a m i l y ' , ' c a l i b r i ' , ' m s o ' , ' h a n s i ' , ' t h e m e ' , ' f o n t ' , ' m i n o r ' , ' l a t i n ' , ' m s o ' , ' b i d i ' , ' f o n t ' , ' f a m i l y ' , ' a r i a l ' , ' m s o ' , ' b i d i ' , ' t h e m e ' , ' f o n t ' , ' m i n o r ' , ' b i d i ' , ' } ' ]

میزبانی شده توسط پلتفرم ابری doprax.com